Depression, Poor Mental Health and CVD Risk In Younger Adults
A study was conducted to determine the effect of depression and poor mental health on cardiovascular health in younger adults in the United States.
A study was conducted to determine the effect of depression and poor mental health on cardiovascular health in younger adults in the United States.
Histologic lesions in the kidney may reflect systemic processes that lead to cardiovascular events, according to investigators.
Olezarsen is an investigational LICA antisense medication designed to inhibit the production of apoC-III for patients at risk of disease due to elevated triglyceride levels.
Furoscix is a pH-neutral formulation of furosemide, a loop diuretic, designed for SC administration via an on-body infusor for outpatient self-administration.
The Trifecta and Trifecta GT valves are heart valve replacement devices designed to treat diseased, damaged, or malfunctioning native or prosthetic aortic heart valves.
The FDA is requiring the Company to conduct an additional clinical trial evaluating omecamtiv mecarbil for HFrEF.
The sNDA is supported by data from the phase 3, placebo-controlled APOLLO-B study.
Matthew L. Springer, PhD, Sandhya Venugopal, MD, and Kinjan Parikh, MD, discuss the effect of e-cigarettes on cardiovascular health.
A study was conducted to determine if the addition of cognitive behavioral therapy to outpatient cardiac rehabilitation reduces anxiety and depression.
The phase 3 EMPEROR-Preserved trial assessed empagliflozin in 5988 adults with heart failure with preserved ejection fraction, with and without diabetes.